Autor: |
Maddux JF; University of Texas Health Science Center at San Antonio, Department of Psychiatry 78284-7792, USA., Prihoda TJ, Vogtsberger KN |
Jazyk: |
angličtina |
Zdroj: |
The American journal on addictions [Am J Addict] 1997 Summer; Vol. 6 (3), pp. 246-55. |
Abstrakt: |
The authors evaluated the relationship of methadone dose to retention in treatment and to urine tests for morphine and cocaine in a cohort of 610 opioid users admitted to methadone maintenance and followed for 1 year. Methadone dosing was flexible, with patient participation in dose decisions. The maximum dose during treatment ranged from 10 mg to 110 mg, with a mean of 52 mg. Higher doses were associated with increased retention through the dose range of 60 mg-69 mg. Dose was not related to the likelihood of a positive morphine test but was related to the likelihood of a positive cocaine test. In this study, with flexible dosing and patient participation in dose decisions, patients were retained on methadone about as well as was reported in a previous study with patients on a fixed dose of 80 mg. |
Databáze: |
MEDLINE |
Externí odkaz: |
|